Clinical Trials, Research and Development
January 17, 2023
Via: PharmaphorumUnify, launched in December 2020, is AstraZeneca’s patient app and clinical trial support tool. Already, it is operating at scale across the company, used in more than 28 countries and available in 62 languages. Dissecting heterogeneity To begin discussions, pharmaphorum […]
January 4, 2023
Via: PharmaphorumThe intention is to streamline the process for patients wishing to access their medical records via electronic health record systems (“EHR systems”) and to facilitate the ability for researchers, innovators, and policy makers to use the data in a trusted […]
November 29, 2022
Via: Pharmaphorum‘Supporting the era of green pharmaceuticals in the UK’ highlights that, while Britain can play a leading role in the sustainability agenda for pharmaceuticals, action must also be taken on a global scale to ensure impact. The pharmaceutical industry’s share […]
Clinical Trials, Research and Development
November 10, 2022
Via: GENCancer cells acquire genetic changes that allow them to grow and proliferate unchecked. Researchers at the Dana-Faber Cancer Institute and colleagues have now found another difference between cancer cells and normal cells. The team analyzed public datasets comprising thousands of […]
November 3, 2022
Via: PharmaphorumBeyond digital clinical measures, digital solutions are maturing to address major challenges facing clinical research and offer enormous promise to support the key performance indicators (KPIs) for every member of our industry. We see how digital measures of adherence ensure […]
October 17, 2022
Via: Biopharma DiveBeginning this week, pharmaceutical executives will be on the spot as they reveal their companies’ earnings for the first time since major drug pricing legislation was enacted in the U.S. The law was a significant defeat for the industry, but […]
September 9, 2022
Via: Drugs.comPeople wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades. Daxxify, made by Revance Therapeutics Inc. in Nashville, Tenn., is […]
September 9, 2022
Via: PharmaphorumPharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. But preparing to adapt to the phenomenon presents an opportunity as well as a challenge. Rising global temperatures will, […]
September 7, 2022
Via: PharmaphorumThe industry’s application of mRNA techniques during the pandemic led to the fastest vaccine development in history. The processes used are now seeing huge infrastructure commitments, in order to cement their place in the development of future products and trials. […]
September 6, 2022
Via: Contract PharmaAptar Pharma, a leader in drug delivery and active material science solutions and services, has acquired Metaphase Design Group Inc., a leader in applying the science of human factors engineering and ergonomics to product design. The acquisition expands Aptar Pharma’s […]
August 30, 2022
Via: PharmaphorumThe 27.5 pence-a-share cash deal values Diurnal at around £48.3 million ($57 million), a 144% premium to the biotech’s closing share price on Friday. Shares in the UK firm had leaped 132% to 26.1 pence at the time of writing […]
Manufacturing, Research and Development
August 29, 2022
Via: Drugs.comLabor shortages at Teva Pharmaceuticals have made Adderall, a widely used attention-deficit/hyperactivity disorder (ADHD) drug, hard to find in some drugstores. But the U.S. Food and Drug Administration noted that there’s no overall shortage of ADHD medications. Only Teva is […]
August 29, 2022
Via: Drugs.comU.S. doctors administered more than 150,000 doses of useless monoclonal antibody treatments to COVID-19 patients early this year, spending loads of cash on therapies that had been deemed of no benefit, a new study has found. The U.S. Food and […]
Manufacturing, Mergers and Acquisitions, Research and Development
August 26, 2022
Via: Contract PharmaElevateBio and the University of Pittsburgh have entered into a long-term partnership to accelerate the development of cell and gene therapies. Through this agreement, ElevateBio will locate one of its next BaseCamp process development and Good Manufacturing Practice (GMP) manufacturing […]
August 25, 2022
Via: PharmaphorumToday on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. […]
Clinical Trials, Research and Development
August 24, 2022
Via: PharmaphorumRemoving barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Getting there, however, is easier said than done. The Food and Drug Administration’s (FDA) draft guidance, Diversity Plans to Improve Enrollment of Participants […]
August 23, 2022
Via: Biopharma DiveThe key ingredient in the coronavirus vaccines developed by Moderna and BioNTech doesn’t last very long. Once in the body, this messenger RNA, or mRNA, degrades within days. Still, that’s enough time for the vaccines to train the body to […]
August 23, 2022
Via: Biopharma DiveAlcon has agreed to acquire Aerie Pharmaceuticals for about $770 million, betting its sprawling commercial presence can boost the uptake of the biotechnology company’s two glaucoma drugs. Alcon, the former eyecare business of Swiss pharmaceutical giant Novartis, will pay $15.25 […]
Clinical Trials, Research and Development
August 22, 2022
Via: Pharma TimesThe phase 3 trials will assess Epidiolex over 14 weeks in a randomised, double-blind, placebo-controlled study, enrolling paediatric patients aged one to 18. It is hoped that Epidiolex will ease symptoms associated with Doose syndrome (EMAS), a rarer type of […]
August 22, 2022
Via: PharmaphorumThe recommendation comes after a review of a clinical trial which found that delivering a smaller dose intradermally – just below the top layer of the skin – is as effective as giving the standard dose subcutaneously as recommended on […]